Sean Dodge
Stock Analyst at RBC Capital
(2.08)
# 2,714
Out of 4,793 analysts
133
Total ratings
29.9%
Success rate
-2.49%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $4.01 | +49.63% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $4.15 | -15.66% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $154.73 | +74.50% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.29 | +64.61% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $153.72 | +71.09% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $9.99 | +70.17% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $24.31 | +31.63% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $7.75 | -22.58% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $78.80 | +33.25% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $10.34 | +64.41% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $34.93 | -2.66% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $25.50 | -45.10% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.12 | +142.72% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.97 | +27.45% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $10.07 | +39.03% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $162.24 | -79.66% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.45 | +12,299.26% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $4.01
Upside: +49.63%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $4.15
Upside: -15.66%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $154.73
Upside: +74.50%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.29
Upside: +64.61%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $153.72
Upside: +71.09%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $9.99
Upside: +70.17%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $24.31
Upside: +31.63%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $7.75
Upside: -22.58%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $78.80
Upside: +33.25%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $10.34
Upside: +64.41%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $34.93
Upside: -2.66%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $25.50
Upside: -45.10%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.12
Upside: +142.72%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $21.97
Upside: +27.45%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $10.07
Upside: +39.03%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $162.24
Upside: -79.66%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.45
Upside: +12,299.26%